 "Unichem Labs hits record high; stock soars 30% in one week")
Unichem Laboratories hit a record high of Rs 339, up 12%, extending its past four days rally on the BSE, after the media report suggested that Torrent Pharma is in talks to buy the company’s domestic business. The stock surpassed its previous high of Rs 334 touched on October 6, 2015 in intra-day trade.
In past one week, the stock of pharmaceuticals Company surged 30% from Rs 260, as compared to 1.6% rise in the S&P BSE Sensex.
On clarification of news report, Unichem Laboratories on Tuesday said that as and when an obligation arises, rest assured an announcement will be made.
“We wish to state that nothing has occurred that requires complaint reporting or confirmation of any development. At this stage any further comment would fuel speculation and would itself be violation of regulatory obligations,” it added.
At 11:49 AM; the stock was up 9% at Rs 331 on the BSE, as compared to 1.1% rise in the S&P BSE Sensex. The trading volumes on the counter nearly doubled with a combined 769,242 shares changed hands on the BSE and NSE so far.
In past one week, the stock of pharmaceuticals Company surged 30% from Rs 260, as compared to 1.6% rise in the S&P BSE Sensex.
On clarification of news report, Unichem Laboratories on Tuesday said that as and when an obligation arises, rest assured an announcement will be made.
“We wish to state that nothing has occurred that requires complaint reporting or confirmation of any development. At this stage any further comment would fuel speculation and would itself be violation of regulatory obligations,” it added.
At 11:49 AM; the stock was up 9% at Rs 331 on the BSE, as compared to 1.1% rise in the S&P BSE Sensex. The trading volumes on the counter nearly doubled with a combined 769,242 shares changed hands on the BSE and NSE so far.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%